Rui Yu

1.7k total citations
40 papers, 1.2k citations indexed

About

Rui Yu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Rui Yu has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 12 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Rui Yu's work include Cell death mechanisms and regulation (10 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (5 papers). Rui Yu is often cited by papers focused on Cell death mechanisms and regulation (10 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (5 papers). Rui Yu collaborates with scholars based in China, Ireland and United Kingdom. Rui Yu's co-authors include Ralf M. Zwacka, Andrea Mohr, Weiliang Sun, Linwen Zhu, Yi Xie, Tianwen Li, Bingxiu Xiao, Yongfu Shao, Liyun Fu and Junming Guo and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Scientific Reports.

In The Last Decade

Rui Yu

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Yu China 21 828 489 180 146 123 40 1.2k
Elham Baghbani Iran 19 756 0.9× 487 1.0× 190 1.1× 131 0.9× 275 2.2× 55 1.2k
Karen Griselda de la Cruz-López Mexico 5 630 0.8× 439 0.9× 141 0.8× 101 0.7× 250 2.0× 8 1.1k
Hee Chan Yoo South Korea 7 635 0.8× 545 1.1× 125 0.7× 99 0.7× 140 1.1× 10 1.1k
Călin Ionescu Romania 14 814 1.0× 447 0.9× 114 0.6× 126 0.9× 265 2.2× 20 1.3k
Yinghui Huang China 18 881 1.1× 360 0.7× 83 0.5× 82 0.6× 205 1.7× 44 1.2k
Kui Sheng Chen China 2 606 0.7× 241 0.5× 97 0.5× 144 1.0× 216 1.8× 5 1.0k
Xiangjin Zheng China 21 1.2k 1.4× 609 1.2× 235 1.3× 252 1.7× 257 2.1× 27 1.7k
Toshiyuki Tsunoda Japan 23 843 1.0× 333 0.7× 149 0.8× 160 1.1× 328 2.7× 77 1.3k
Hui Xing China 22 768 0.9× 387 0.8× 122 0.7× 100 0.7× 343 2.8× 54 1.2k
Carmen Aanei France 12 484 0.6× 205 0.4× 151 0.8× 92 0.6× 219 1.8× 22 979

Countries citing papers authored by Rui Yu

Since Specialization
Citations

This map shows the geographic impact of Rui Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Yu more than expected).

Fields of papers citing papers by Rui Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Yu. The network helps show where Rui Yu may publish in the future.

Co-authorship network of co-authors of Rui Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Yu. A scholar is included among the top collaborators of Rui Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Yu. Rui Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yi, Zejun Yan, Kejie Wang, et al.. (2025). Sinularin induces autophagy-dependent cell death by activating ULK1 and enhancing FOXO3-ATG4A axis in prostate cancer cells. Scientific Reports. 15(1). 15875–15875. 2 indexed citations
2.
Shen, Hongping, et al.. (2024). Enniatin B1 induces damage to Leydig cells via inhibition of the Nrf2/HO-1 and JAK/STAT3 signaling pathways. Ecotoxicology and Environmental Safety. 273. 116116–116116. 3 indexed citations
3.
Deng, Yanhui, et al.. (2023). The U1 antisense morpholino oligonucleotide (AMO) disrupts U1 snRNP structure to promote intronic PCPA modification of pre-mRNAs. Journal of Biological Chemistry. 299(7). 104854–104854. 6 indexed citations
4.
Yu, Rui, et al.. (2022). Icariside II induces ferroptosis in renal cell carcinoma cells by regulating the miR-324-3p/GPX4 axis. Phytomedicine. 102. 154182–154182. 55 indexed citations
6.
Nie, Chun‐Hui, et al.. (2021). Protopine triggers apoptosis via the intrinsic pathway and regulation of ROS/PI3K/Akt signalling pathway in liver carcinoma. Cancer Cell International. 21(1). 396–396. 26 indexed citations
7.
Ren, Yu, et al.. (2021). Alternol Sensitizes Renal Carcinoma Cells to TRAIL-Induced Apoptosis. Frontiers in Pharmacology. 12. 560903–560903. 5 indexed citations
8.
Ma, Qi, et al.. (2019). Sinularin exerts anti-tumor effects against human renal cancer cells relies on the generation of ROS. Journal of Cancer. 10(21). 5114–5123. 21 indexed citations
9.
Yang, Yang, Gang Wang, Wenjun Wu, et al.. (2018). Camalexin Induces Apoptosis via the ROS‐ER Stress‐Mitochondrial Apoptosis Pathway in AML Cells. Oxidative Medicine and Cellular Longevity. 2018(1). 7426950–7426950. 30 indexed citations
10.
Zhao, Yi, Enfan Zhang, Ning Lv, et al.. (2018). Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells. Cellular Physiology and Biochemistry. 48(2). 785–800. 22 indexed citations
11.
Liang, Wei, Shanshan Mao, Shijie Sun, et al.. (2018). Core Fucosylation of the T Cell Receptor Is Required for T Cell Activation. Frontiers in Immunology. 9. 78–78. 62 indexed citations
13.
Li, Tianwen, Yongfu Shao, Liyun Fu, et al.. (2017). Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection. Journal of Molecular Medicine. 96(1). 85–96. 228 indexed citations
14.
Yu, Jie, Jiajia Lin, Rui Yu, et al.. (2017). Fucoxanthin prevents H2O2-induced neuronal apoptosis via concurrently activating the PI3-K/Akt cascade and inhibiting the ERK pathway. Food & Nutrition Research. 61(1). 1304678–1304678. 64 indexed citations
15.
Shen, Zhisen, Xiaoying Chen, Qun Li, et al.. (2016). Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients. Clinical Biochemistry. 49(16-17). 1278–1282. 20 indexed citations
16.
Mohr, Andrea, Rui Yu, & Ralf M. Zwacka. (2015). TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill. BMC Cancer. 15(1). 494–494. 23 indexed citations
17.
Li, Wenzhe, Rui Yu, Biao Ma, et al.. (2015). Core Fucosylation of IgG B Cell Receptor Is Required for Antigen Recognition and Antibody Production. The Journal of Immunology. 194(6). 2596–2606. 70 indexed citations
18.
Yu, Rui, Stella Maris Albarenque, Robbert H. Cool, et al.. (2014). DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer. Cancer Biology & Therapy. 15(12). 1658–1666. 24 indexed citations
19.
Yu, Rui, Laura Deedigan, Stella Maris Albarenque, Andrea Mohr, & Ralf M. Zwacka. (2013). Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects. Cell Death and Disease. 4(2). e503–e503. 36 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026